Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the appointment of Betty Jo Rocchio, DNP, RN, CRNA, CENP, EBP-C, to its Board of Directors, succeeding Lisa Colleran, who stepped …
TELA Bio Appoints Healthcare Leader Betty Jo Rocchio to Board of Directors Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that it will present new data on its investigational oncolytic peptide therapy, VP-315, for the treatment of basal cell carcinoma …
Verrica Pharmaceuticals to Present Phase 2 Data on VP-315 at Major Immunotherapy Conference Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) announced it will release its financial results for the third quarter of 2025 before the market opens on Wednesday, November 5, 2025. …
Bentley Systems to Announce Third Quarter 2025 Financial Results on November 5 Read More
WEST CHESTER, PA — QVC Group, Inc. (Nasdaq: QVCGA, QVCGP; OTCQB: QVCGB) announced it will release its third-quarter 2025 financial results before market open on Wednesday, November 5. The company …
QVC Group Sets Nov. 5 Call to Discuss Third-Quarter 2025 Results Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that its leadership team will present at three upcoming industry and investor events: the 2025 Cell & Gene Meeting on the Mesa, …
Ocugen to Highlight Gene Therapy Pipeline at Key Industry and Investor Conferences Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced it will hold its 2025 R&D Day in Midtown, New York, on Tuesday, October 14, at 8:00 a.m. ET. The event …
Aclaris to Host 2025 R&D Day in New York to Spotlight Immuno-Inflammatory Pipeline Read More
WAYNE, PA — Hartford Funds has launched the Hartford Dynamic Bond ETF (Nasdaq: DYNB), an actively managed multisector bond strategy designed to help investors navigate market volatility. The fund is …
Hartford Funds Launches Dynamic Bond ETF to Tackle Market Volatility Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced it will expand development of its investigational therapy QTORIN™ 3.9% rapamycin anhydrous gel into clinically significant angiokeratomas, a rare and debilitating …
Palvella Expands QTORIN Rapamycin Program Into Rare Angiokeratomas Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced it has completed TOIVA, a Phase 2 proof-of-concept trial of QTORIN™ 3.9% rapamycin anhydrous gel, for the treatment of cutaneous venous …
Palvella Completes Phase 2 Trial of QTORIN Rapamycin for Cutaneous Venous Malformations Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has signed an exclusive licensing agreement with South Korea’s Kwangdong Pharmaceutical Co., Ltd. for the rights to commercialize OCU400, its experimental modifier gene …
Ocugen Strikes $7.5 Million Licensing Deal With Kwangdong for Gene Therapy in Korea Read More